What Laboratorios Syva does

Laboratorios Syva is a privately held Spanish veterinary pharmaceutical company founded in 1941 and headquartered in León's Technology Park. It develops, registers, manufactures, and distributes vaccines and antibiotics — both immunologicals (viral and bacterial, live and inactivated) and betalactam anti-infectives — for livestock (bovine, porcine, ovine, caprine, poultry, equine) and companion animals (cats, dogs), with additional coverage of fish, deer, and other species. Its manufacturing footprint comprises three dedicated plants in Spain: the historical Planta Farmacoló gicos (since 1941), the Planta Inmunológicos (inaugurated 2008, covering over 12,000 m² with 13.5 million unit / 675 million vaccine dose annual capacity), and the Planta Betalactámicos (relocated in 2017 to the Technology Park).

The company's commercial model combines direct sales in Spain, three wholly owned subsidiaries in Portugal (IAPSA), Mexico (founded 1993), and Turkey (established 2020), and a network of exclusive and authorized distributors covering more than 60 countries organized into three regional areas. Revenue is generated primarily through sale of veterinary pharmaceuticals under prescription, supplemented by contract manufacturing services (CMO) for third parties in betalactams and immunologics. Differentiated offerings include ORBYK EHD — the first and only EU-authorized DIVA subunit vaccine against Epizootic Hemorrhagic Disease in cattle — and Syvazul BTV3 for Bluetongue serotype 3, both targeting vector-borne diseases. Syva also operates SyvaStart, an open R&D collaboration platform with universities and research centers (Universidad de León, CNB, VISAVET/UCM, Universidad de Santiago de Compostela, CIBIR, ANSES), and runs the long-standing Premio SYVA Internacional thesis award.

Syva is governed as a privately held corporation (LABORATORIOS SYVA, S.A.), with no identified parent entity, institutional investor, or public listing. Operations are led by CEO Cesar Carnicer, and the company maintains active memberships in the Spanish industry association Veterindustria and the European federation AnimalhealthEurope.

Name

Laboratorios Syva

Legal name

LABORATORIOS SYVA, S.A.

Website

https://syva.es

Company type

Private

Founded year

1941

Operating status

Operating

Headcount range

101–250 employees

Short description

Laboratorios Syva is a privately held Spanish veterinary pharmaceutical company, founded in 1941, that develops, manufactures, and distributes vaccines and antibiotics for livestock and companion animals across more than 60 countries via three wholly owned subsidiaries and a global distributor network.

Ownership category

akta.pro rank

Product category

Veterinary Pharmaceuticals

SIC

Agricultural Prod-Livestock & Animal Specialties (200)

akta.pro primary industry

Vaccine Manufacturing & Contract Services (Veterinary Vaccine CDMO) (HLAMAKAI)

Keywords

• Veterinary pharmaceuticals
• Livestock vaccines
• Animal antibiotics
• Veterinary biologics
• Contract manufacturing

Headquarters

HQ city

León

HQ country

Spain

HQ region

Europe

Offices6 records

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Operations, Personnel, Technology or R&D, Supply Chain, Marketing or Sales, Infrastructure

Revenue model

1. Veterinary Pharmaceuticals Sales: Sale of vaccines and antibiotics for livestock (bovine, porcine, ovine, caprine, poultry, fish, equine) and companion animals (cats, dogs). Products include vaccines for vector-borne diseases (EHE, Bluetongue) and anti-infectives including betalactams.
2. Contract Manufacturing (CMO): Syva offers contract manufacturing services for third parties with direct involvement in all stages of the process. They provide technical, regulatory, and scientific support during all phases for betalactams and immunologics manufacturing.

Go-to-market motion1 record

Distribution channels6 records

Marketing channels7 records

Core offering

Laboratorios Syva is a Spanish veterinary pharmaceutical manufacturer that develops, registers, and commercializes vaccines (immunologics) and antibiotics (betalactams and other anti-infectives) for livestock (bovine, porcine, ovine, caprine, poultry, fish, equine) and companion animals (cats, dogs). The company also offers contract manufacturing services for third parties, leveraging three own manufacturing plants in Spain with capacity of 13.5 million units (675 million vaccine doses) annually.

Product overview

Laboratorios Syva is a veterinary pharmaceutical company specializing in animal health solutions, primarily offering vaccines (immunologicals) and antibiotics (betalactámicos and pharmacologicals) for livestock and companion animals. The company operates three manufacturing plants in Spain producing vaccines (covering 12,000 m² with capacity of 13.5 million units/675 million doses), beta-lactam antibiotics, and general pharmaceutical products. Syva's product portfolio spans multiple animal species (porcine, bovine, ovine, caprine, poultry, fish, equine, feline, canine, deer) and includes notable vaccines such as ORBYK EHD (EHE DIVA vaccine), Syvazul® BTV3 (Bluetongue vaccine), and Syvac® Ery Parvo. The company also offers contract manufacturing services (CMO) and operates internationally through subsidiaries in Portugal, Mexico, and Turkey, plus distribution networks in over 60 countries.

Differentiator

Problem solved

Functional benefit

Products and services

• ORBYK EHD (formerly Syvac EH Marker) First and only DIVA (Differentiating Infected from Vaccinated Animals) subunit vaccine providing differentiated protection against Epizootic Hemorrhagic Disease (EHD) caused by serotype 8 in cattle. The only European market vaccine enabling differentiation between infected and non-infected animals.
• Syvazul BTV3 Vaccine for Bluetongue serotype 3 (BTV3) providing protection against this vector-borne disease transmitted by Culicoides midges, authorized for use in sheep and cattle.
• Syvac Ery Parvo Vaccine for simultaneous control of Mal Rojo (Erysipelas) and Porcine Parvovirus (PPV) in pig herds, enabling individualized control protocols for each farm.
• Immunologicals and Vaccines Portfolio Complete portfolio of vaccines (viruses, bacteria, live or inactivated) produced at the dedicated Immunologicals plant, covering multiple animal species for prevention of vector-borne and infectious diseases.
• Betalactam Antibiotics Pharmaceutical specialties incorporating beta-lactam active principles (antibiotics) for veterinary use, manufactured at the dedicated plant in León's technology park.
• Pharmacological Products Farm medications and related pharmaceutical products, including serums and vaccines, produced at the historical Pharmacologicals plant since 1941.
• Contract Manufacturing (CMO) Services Contract manufacturing services offering technical, regulatory, and scientific support during all phases of development, registration, and manufacturing of vaccines and antibiotics for third parties, leveraging three owned manufacturing sites in Spain.

Quantifiable outcome

• Production capacity of 675 million vaccine doses annually at immunologics plant
• +2 more outcomes

Named customers2 records

Segments4 records

Ideal customer profiles4 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature3 records

Partnerships

Eight partnerships are on record, tiered core and secondary.

• VeterindustriacoreOthersSpanish Business Association of the Animal Health and Nutrition Industry. Founded 1977, works in defense of interests of Spanish companies dedicated to manufacturing and/or commercialization of veterinary medicines, animal health and nutrition products, and nutritional additives. Represents nearly all companies in the sector.
• AnimalhealthEuropecoreOthersAssociation representing manufacturers of animal medicines, vaccines, and other animal health products in Europe. Non-profit organization representing corporate members and national associations. Membership covers 90% of the European animal health products market.
• Universidad de LeóncoreStrategic or Co-development PartnerAcademic partner for research collaborations. Co-organizer of Premio SYVA Internacional award and host of annual ceremony. Also hosts R&D laboratories at the university.
• Centro Nacional de Biotecnología (CNB)secondaryStrategic or Co-development PartnerNational research center for biotechnology, part of the SyvaStart network for collaborations with academic institutions.
• Universidad Complutense de Madrid (VISAVET)secondaryStrategic or Co-development PartnerUniversity research center part of the SyvaStart network for collaborations in animal health research.
• Universidad de Santiago de CompostelasecondaryStrategic or Co-development PartnerGalician university partner in the SyvaStart network for animal health research collaborations.
• CIBIR (Centro de Investigación Biomédica de La Rioja)secondaryStrategic or Co-development PartnerBiomedical research center in La Rioja, part of the SyvaStart research network.
• ANSES (Agence nationale de sécurité sanitaire de l'alimentation, de l'environnement et du travail)secondaryStrategic or Co-development PartnerFrench food, environment and occupational health safety agency. Part of SyvaStart network for international research collaborations in animal health.

Scale indicators9 records

Recent moves7 records

Expansion highlights6 records

Direct peers

• Hipra: Spanish-headquartered veterinary pharmaceutical company specializing in vaccines and immunology for livestock and companion animals. Closest geographic and product peer to Syva, both based in Catalonia/León region with comparable species coverage and CMO capabilities for veterinary biologics.
• Ceva Santé Animale: French-headquartered global animal health company focused on vaccines, pharmaceuticals, and equipment for livestock and companion animals. Comparable to Syva in species breadth and vaccine-led portfolio, though at materially larger scale.
• Virbac: French-listed global animal health company offering vaccines, parasiticides, and pharmaceuticals for livestock and pets. Similar mid-sized independent positioning, multi-species portfolio, and CMHO/CDMO relevance to Syva, making it a key structural comparator.
• Vetoquinol: Independent French-listed animal health company with a portfolio of pharmaceuticals and vaccines for livestock and companion animals. Comparable mid-sized European competitor with similar species and therapeutic-area coverage to Syva.
• Phibro Animal Health: US-listed animal health and nutrition company with significant livestock pharmaceutical and vaccine businesses, including a meaningful nutritional/health products portfolio. Mid-sized independent competitor with overlapping species focus and therapeutic categories.

Broad incumbents

• Zoetis: World's largest animal health company offering vaccines, anti-infectives, parasiticides, and diagnostics across livestock and companion animals. Competes with Syva in core vaccine and antibiotic categories but at significantly larger scale and broader geographic footprint.
• Boehringer Ingelheim Animal Health: Global animal health division of Boehringer Ingelheim and a top-three player in livestock vaccines, including strong positions in bovine and porcine biologicals. Directly competes with Syva in livestock vaccines and therapeutics across the EU and global markets.
• Elanco Animal Health: Large US-listed global animal health company offering livestock vaccines, antibiotics, parasiticides, and companion animal therapeutics. Overlaps with Syva in livestock pharmaceuticals and anti-infectives at a much larger scale.
• MSD Animal Health (Merck Animal Health): Animal health division of Merck & Co., a global leader in livestock and companion animal vaccines and pharmaceuticals. Competes with Syva in vector-borne disease vaccines (Bluetongue, EHD) and in core livestock anti-infectives, with vastly deeper R&D resources.

Emerging players

• Indian Immunologicals Limited: India-based veterinary vaccine manufacturer with growing presence in livestock and aquaculture biologics in Asia, Africa, and Latin America. Earlier-stage and geographically focused, but operationally relevant as a low-cost veterinary vaccine producer competing in emerging markets where Syva also distributes.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

• Facebookfacebook.com/syvacontigo
• LinkedInlinkedin.com/company/laboratorios-syva
• Xx.com/syvacontigo

Compliance3 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles1 record

Subsidiaries3 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Laboratorios Syva